% Expired Patents = 25.0

Forward Citations = 14

Loading Chart...

6 inventors (with patents filed for the assignee):

Ragupathy Madiyalakan (4 out of 16 patents)

Antoine A Noujaim (3 out of 18 patents)

Beatrice Leveugle (2 out of 3 patents)

4. Birgit Corinna Schultes (2 out of 8 patents)

5. Birgit Schultes (1 out of 3 patents)

6. Richard Baum (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 7579445 - Reagents and methods for inducing an immune response to prostate specific antigen (2009-08-25),

2. 7318921 - Therapeutic compositions that alter the immune response (2008-01-15),

3. 7147850 - Therapeutic binding agents against MUC-1 antigen and methods for their use (2006-12-12),

4. 6881405 - Reagents and methods for inducing an immune response to prostate specific antigen (2005-04-19),

Company Overview

Altarex Medical Corp. is a leading biotechnology company specializing in the development of innovative medical technologies for the healthcare industry. With a strong focus on research and development, Altarex is dedicated to providing cutting-edge solutions to improve patient outcomes and advance the field of medical science. Our team of experts is committed to delivering quality products that meet the highest standards of safety and efficacy. Visit our website to learn more about our products and services.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#71 in Edmonton

#3,466 in Canada

Edmonton, Canada

Altarex Medical Corp.

Forward Citations = 14

6 inventors:

Ragupathy Madiyalakan (4 out of 16 patents)

Antoine A Noujaim (3 out of 18 patents)

Beatrice Leveugle (2 out of 3 patents)

4. Birgit Corinna Schultes (2 out of 8 patents)

5. Birgit Schultes (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Altarex Medical Corp.. Retrieved from https://idiyas.com/company/altarex-medical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]